论文部分内容阅读
血液透析(以下简称血透)已成为近代尿毒症替代治疗的重要手段,随着血透技术的广泛开展,积极防治各类并发症是提高维持性血透患者存活的关键。本文着重就36例尿毒症患者血透前后心血管并发症的变化情况报告如下。 1 临床资料 病例选择:(1)性别与年龄:男26例,女10例,年龄22～69岁,平均40.5±12.2岁。(2)原发病:慢性肾炎29例,慢性肾盂肾炎4例,多囊肾1例,肾结核1例,梗阻性肾病1例。(3)透析前实验室检查:血肌酐1012.4±208.3μmol/L,血尿素氮40.3±10.5mmol/L。
Hemodialysis (hereinafter referred to as hemodialysis) has become an important means of modern uremic replacement therapy. With the extensive application of hemodialysis technique, active prevention and treatment of various complications are the key to improve the survival of maintenance hemodialysis patients. This article focuses on 36 cases of uremic patients before and after hemodialysis cardiovascular complications reported as follows. 1 Clinical data Case Selection: (1) gender and age: 26 males and 10 females, aged 22 to 69 years, mean 40.5 ± 12.2 years old. (2) The primary disease: chronic nephritis in 29 cases, 4 cases of chronic pyelonephritis, polycystic kidney disease in 1 case, renal tuberculosis in 1 case, 1 case of obstructive nephropathy. (3) Pre-dialysis laboratory tests: serum creatinine 1012.4 ± 208.3μmol / L, blood urea nitrogen 40.3 ± 10.5mmol / L.